Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery

The Cochrane Database of Systematic Reviews
S SivaprasadRoxanne Crosby-Nwaobi

Abstract

Cystoid macular oedema (CMO) is the accumulation of fluid in the central retina (the macula) due to leakage from dilated capillaries. It is the most common cause of poor visual outcome following cataract surgery. The exact cause is unclear. Acute CMO, defined as oedema of less than four months duration, often resolve spontaneously. CMO that persists for four months or more is termed chronic CMO. Different types of non-steroidal anti-inflammatory agents (NSAIDs) are used in the treatment of CMO which may be delivered topically or systemically. To examine the effectiveness of NSAIDs in the treatment of CMO following cataract surgery. We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2011, Issue 7), MEDLINE (January 1950 to August 2011), EMBASE (January 1980 to August 2011), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to August 2011), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com) (August 2011) and ClinicalTrials.gov (www.clinicaltrials.gov) (August 2011). We searched the reference lists of identified trials. We searched conference abstracts (sessions related to cataract) in The Association for Research...Continue Reading

References

Oct 1, 1977·American Journal of Ophthalmology·L A YannuzziI Katiz
Jul 1, 1985·Journal - American Intra-Ocular Implant Society·M C KraffH L Lieberman
May 1, 1984·Survey of Ophthalmology·W J StarkC Auer
Jan 1, 1995·Journal of Cataract and Refractive Surgery·L Drolsum, E Haaskjold
Feb 1, 1995·Current Opinion in Lipidology·J C LaRosa
Jul 1, 1994·Archives of Ophthalmology·L M JampolR N Weinreb
Mar 21, 2000·Current Opinion in Ophthalmology·L Rossetti, A Autelitano
May 1, 1953·American Journal of Ophthalmology·S R IRVINE
Jan 8, 2004·Journal of Cataract and Refractive Surgery·David S Rho
Jun 8, 2004·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Neera Singal, Jill Hopkins
Jan 28, 2005·The Cochrane Database of Systematic Reviews·S SivaprasadN Patel
May 11, 2006·BMC Medical Research Methodology·Li ZhangMargaret Sampson

❮ Previous
Next ❯

Citations

Nov 15, 2013·Mediators of Inflammation·Andrea RussoFrancesco Semeraro
Apr 26, 2016·Acta Ophthalmologica·Susanna Porela-TiihonenMerja Kokki
Apr 4, 2017·Journal of Cataract and Refractive Surgery·Laura H P WieldersRudy M M A Nuijts
Feb 17, 2015·The Cochrane Database of Systematic Reviews·Soumendra SahooN S Nair
Jul 4, 2017·The Cochrane Database of Systematic Reviews·Viral V JuthaniRoy S Chuck
Apr 7, 2016·Journal of Ophthalmic & Vision Research·Zhaleh RajaviKourosh Sheibani
Oct 23, 2012·Journal of Cataract and Refractive Surgery·Mark PackerHoward Fine
Jan 29, 2017·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ping DuanJiawen Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.